Tanya Heare-Rowlands

Special Counsel
theare-rowlands@cooley.com
Full contact info

I enjoy getting to know my client’s business and developing an intellectual property strategy to match their business needs and provide a competitive advantage.

About Tanya

Tanya is a Chartered & European Patent Attorney and also a European Patent Litigator. Previously a partner in a respected patent and trade mark firm, Tanya brings extensive experience in patents and applications in the life sciences field to Cooley’s London team. 

View full bio

Passions

Scuba diving

Adventure travel

Experience

Sixth Street Invests in Blueprint Medicines

Sixth Street Invests in Blueprint Medicines

July 7, 2022

Cooley advised global investment firm Sixth Street on its strategic investment in Blueprint Medicines, a global precision therapy company that invents life-changing therapies for people with cancer and blood disorders. Lawyers Mischi a Marca, Matt Browne, Matt Scarano, Addison Pierce, Matt Kong and Nick Neuteufel led the Cooley team advising Sixth Street. 

Read more

Related contacts

Mischi a Marca
Partner, San Francisco
Matt Browne
Partner, San Diego
Matthew S. Scarano
Associate, San Diego
Addison Pierce
Associate, Chicago
Matt Kong
Associate, San Francisco
Michael Tuscan
Partner, Washington DC
Jon Cousin
Associate, Washington DC
Tanya Heare-Rowlands
Special Counsel, London
Matthew Everhart
Patent Agent, Washington DC
Jeffery Wyzykowski
Patent Agent, Washington DC
Matthew Scheideman
Patent Agent, Washington DC
Charity Williams
Partner, San Diego
Freddy Yip
Associate, Hong Kong
Zack Gong
Associate, Shanghai
Natasha Leskovsek
Of Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Elizabeth Anne Wright
Partner, Brussels
Aaron Pomeroy
Partner, Colorado
Michael Klein
Partner, New York
Paul Springer
Associate, New York
Megan Browdie
Partner, Washington DC
Howard Morse
Partner, Washington DC

Related Practices & Industries

Debt Finance
Private Equity
Public Companies
Life Sciences

Forbius Agrees to Sell to Bristol Myers Squibb

Forbius Agrees to Sell to Bristol Myers Squibb

August 25, 2020

Cooley advised Forbius – a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases – on its agreement to sell to Bristol Myers Squibb. Barbara Borden, Marya Postner and Rowook Park led the Cooley team advising Forbius. 

Read more

Related contacts

Rowook Park
Partner, San Diego
Barbara Borden
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
David Dalton
Associate, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Lindsey O'Crump
Associate, Washington DC
Marya Postner
Partner, Palo Alto
Michael Tuscan
Partner, Washington DC
Aaron Pomeroy
Partner, Colorado
Barbara Mirza
Partner, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Dionne A. Thomas
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Jane Adams
Partner, San Diego
Jeffery Wyzykowski
Patent Agent, Washington DC
Phil Mitchell
Partner, New York
Steve Cuss
Associate, London
Tanya Heare-Rowlands
Special Counsel, London

Related Practices & Industries

Mergers & Acquisitions
Life Sciences
Life Sciences Corporate Partnering & Licensing
Antitrust & Competition
Public Companies
Compensation & Benefits
Intellectual Property
Tax

Memberships & affiliations

European Patent Institute

Fellow, Chartered Institute of Patent Attorneys

Tanya is a commercially-savvy patent attorney that you can talk business with, not just legal details

Dr. Piers Mahon, Director, Global Alliances at Cancer Commons